QantX Ltd has achieved direct authorisation from the UK's Financial Conduct Authority (FCA), effective from 23 October 2026.
The South West-based venture capital firm backs early-stage companies in the South and South West of the UK, including spinouts from universities and research institutions. Its focus spans sustainability, healthcare and deep technology. The team's angel investing dates back to 2019, before QantX Ltd was incorporated in May 2021.
QantX leads funding rounds and invests up to £750,000 before Series A. It provides commercial guidance and introductions and takes board seats at portfolio companies.
The firm previously operated as an appointed representative of Kin Capital Partners LLP, a relationship that began in 2021. It now has investment-related permissions, including managing unauthorised alternative investment funds (AIFs).
Richard Haycock is Co-Founder and Chief Executive Officer and holds the SMF1 Chief Executive and SMF3 Executive Director roles. He previously worked as a Senior Director at Oracle, where he was part of the Global Enterprise Cloud team.
Richard Olver is Co-Founder and Chairman and holds the SMF3 Executive Director and SMF9 Chair of the Governing Body roles. He chaired BAE Systems from 2004 to 2014, following a career at BP that included serving as Deputy Group Chief Executive.
Roger Killen is Co-Founder and Investment Partner and holds the SMF3 Executive Director role. He co-founded hospital benchmarking business Dr Foster and founded The Learning Clinic, which developed electronic observation systems for nurses.
Mark Yallop is Co-Founder and Deputy Chair. His background includes serving as Chief Executive Officer of UBS UK and Chief Operating Officer at ICAP and Deutsche Bank.
William Alexander holds the SMF16 Compliance Oversight and SMF17 Money Laundering Reporting Officer roles.
